Mylan to Present at the 25th Annual JPMorgan Healthcare ConferencePITTSBURGH, Jan 03, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Mylan Laboratories Inc. (NYSE: MYL) today announced that Mylan's Vice Chairman and CEO Robert J. Coury will present at the 25th Annual JPMorgan Healthcare Conference Tuesday, Jan. 9, at 3:30 p.m. PT at the Westin St. Francis Hotel, San Francisco.

Mylan Laboratories Inc. is a leading pharmaceutical company with three principal subsidiaries: Mylan Pharmaceuticals Inc., Mylan Technologies Inc. and UDL Laboratories Inc. Mylan develops, licenses, manufactures, markets and distributes an extensive line of generic and proprietary products. For more information about Mylan, please visit www.mylan.com.

SOURCE Mylan Laboratories Inc.

Patrick Fitzgerald of Mylan Laboratories Inc., +1-724-514-1800

http://www.mylan.com